Vascular Inflammation in Psoriasis Trial (The VIP Trial)

NCT01553058 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Cardiovascular Disease

Interventions

DRUG: Adalimumab (Humira)
DRUG: Placebo Injection
OTHER: NB-UVB phototherapy

Sponsor

University of Pennsylvania